Pharmacotherapies for Co-Occurring Substance Use and Bipolar Disorders: A Systematic Review.

29 clinical studies, which evaluated both mental health and SUD outcomes in patients with co-occurring bipolar disorders and SUDs. RESULTS: Our findings suggest the potential of valproate sodium and lamotrigine as preferred pharmacological agents for the treatment of co-occurring psychiatric and substance use outcomes in these patients. However, many of Read more…

Partage le savoir
error: Content is protected !!